glp-1 overdose Weight loss drugs and addiction: Study shows may help reduce risks Popular GLP-1 weight-loss drugs linked

While he notes Novo Nordisk's pill as "important" to consumers, it's Eli Lilly's injectable he sees continuing to lead GLP-1 momentum

Discover insights on discontinuation rates

Weight loss is known to trigger compensatory biology: Increased appetite signaling Reduced resting energy expenditure Heightened food reward sensitivity Stopping GLP-1 therapy at peak dose, without tapering and without reinforcing lifestyle strategies at the exact moment hunger returns, does not allow lifestyle behaviors to take over. Emerging real-world data and obesity physiology suggest a different, more clinically relevant path: Gradual dose reduction rather than abrupt cessation Continued, structured dietary and exercise support Active monitoring during the high-risk post-cessation period We still need randomized trials designed specifically to test tapering and lifestyle-anchored maintenance strategies

The landscape of weight management has expanded with new research shedding light on hormones like GLP-1 (glucagon-like peptide-1) and innovative supplements like Curb by Modere

The internet is buzzing with claims about the ZVOEVO SMGT-GLP-1 Nano Microneedle Patch, hailed as a revolutionary way to manage blood sugar and lose